Skip to main content

Want a detailed portfolio tracker?

Comparison Rein Therapeutics (RNTX) with Competitors

Rein Therapeutics (RNTX) industry is Biotechnology.

Free Cash Flow Yield
RNTX-37.38%
Industry-1.75%
Upside-35.63%
P/E
RNTX-0.97
Industry-20.52
Upside+1954.24%
P/B
RNTX28.17
Industry5.15
Upside+447.33%